Clinical Trial Update: CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity

View source ↗

Summary

This clinical trial update describes caregiver burden, effectiveness, and other health care outcomes in patients with upper limb spasticity treated with abobotu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Limb Spasticity

Drugs mentioned

• AbobotulinumtoxinA (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Upper Limb Injury | Status: ACTIVE_NOT_RECRUITING